Two Vaccines to Prevent Ebola Virus Show Promise in Trial

October 13, 2017

ChAd3-EBO-Z, rVSVG-ZEBOV-GP vaccines elicit response that is maintained through 12 months

Recombinant Type-5 Vector-Based Ebola Vaccine Appears Safe, Effective

December 27, 2016

Vaccine is immunogenic in healthy adults from Sierra Leone; optimal dose 8.0 1010 viral particles